Literature DB >> 15205244

Activation of nuclear factor-kappa B in the conjunctiva with the epithelial scraping of the mouse cornea and human epidemic keratoconjunctivitis.

S Kase1, K Aoki, T Harada, C Harada, K Ohgami, K Shiratori, S Nishi, S Ohno, K Yoshida.   

Abstract

AIM: To examine the expression of p65, one of nuclear factor-kappa B (NF-kappa B), in the conjunctival epithelium of the C57Bl6 mouse and a patient with epidemic keratoconjunctivitis (EKC).
METHODS: Normal and epithelial scraped cornea obtained 6 hours after the injury were processed for paraffin section. Samples of a normal and an EKC conjunctival epithelium were obtained using impression cytology. Both samples were analysed by immunocytochemistry using anti-p65 antibody.
RESULTS: Immunocytochemistry with the anti-NF-kappa B p65 antibody revealed that p65 was localised in the cytoplasm of the conjunctival epithelium in the C57Bl6 mouse without the treatment. Six hours after the scraping of the cornea, p65 protein was expressed in the nuclei of the conjunctival epithelium. p65 was localised in the cytoplasm of the conjunctival epithelium in the human normal eye. p65 protein was expressed in the nuclei of the conjunctival epithelial cells in the EKC patient.
CONCLUSION: These findings suggest that NF-kappa B was activated in the conjunctiva in the epithelial scraping of the mouse cornea and in human EKC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15205244      PMCID: PMC1772208          DOI: 10.1136/bjo.2003.024646

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  19 in total

1.  NF-kappa B: ten years after.

Authors:  P A Baeuerle; D Baltimore
Journal:  Cell       Date:  1996-10-04       Impact factor: 41.582

Review 2.  Epidemiology of epidemic keratoconjunctivitis.

Authors:  E Ford; K E Nelson; D Warren
Journal:  Epidemiol Rev       Date:  1987       Impact factor: 6.222

3.  Corneal perforation in Mooren's ulcer--immunological and clinical follow-up.

Authors:  A Parunović; S Brkić; S Vucković
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

Review 4.  E3 transcription unit of adenovirus.

Authors:  W S Wold; A E Tollefson; T W Hermiston
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

Review 5.  NF-kappa B and rel proteins in innate immunity.

Authors:  E B Kopp; S Ghosh
Journal:  Adv Immunol       Date:  1995       Impact factor: 3.543

6.  Immunohistochemical detection of bFGF and TNF-alpha in the course of inflammatory angiogenesis in the mouse cornea.

Authors:  C Sunderkötter; J Roth; C Sorg
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

7.  Conjunctival cytologic features of primary Sjögren's syndrome.

Authors:  S C Pflugfelder; A J Huang; W Feuer; P T Chuchovski; I C Pereira; S C Tseng
Journal:  Ophthalmology       Date:  1990-08       Impact factor: 12.079

8.  Lymphoid specific gene expression of the adenovirus early region 3 promoter is mediated by NF-kappa B binding motifs.

Authors:  J L Williams; J Garcia; D Harrich; L Pearson; F Wu; R Gaynor
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

9.  Adenovirus type 37 uses sialic acid as a cellular receptor on Chang C cells.

Authors:  Niklas Arnberg; Patricia Pring-Akerblom; Göran Wadell
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 10.  A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan.

Authors:  Koki Aoki; Yoshitugu Tagawa
Journal:  Int Ophthalmol Clin       Date:  2002
View more
  2 in total

1.  Dietary zerumbone prevents mouse cornea from UVB-induced photokeratitis through inhibition of NF-κB, iNOS, and TNF-α expression and reduction of MDA accumulation.

Authors:  Bo-Yie Chen; David Pei-Cheng Lin; Chia-Yung Wu; Mei-Ching Teng; Chi-Yun Sun; Yuan-Ting Tsai; Kuo-Chen Su; Soo-Ray Wang; Han-Hsin Chang
Journal:  Mol Vis       Date:  2011-04-06       Impact factor: 2.367

2.  A natural tetranortriterpenoid with immunomodulating properties as a potential anti-HSV agent.

Authors:  Carlos A Bueno; Andrea A Barquero; Hernán Di Cónsoli; Marta S Maier; Laura E Alché
Journal:  Virus Res       Date:  2009-01-20       Impact factor: 3.303

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.